Second to none

Research output: Contribution to journalComment/debatepeer-review

6 Scopus citations


In this issue of Blood, Usmani et al provide important information on second primary malignancies in patients treated with thalidomide and lenalidomide in the Arkansas total therapy trials.

Original languageEnglish (US)
Pages (from-to)1537-1539
Number of pages3
Issue number8
StatePublished - Aug 23 2012

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Fingerprint Dive into the research topics of 'Second to none'. Together they form a unique fingerprint.

Cite this